Treatment and diagnosis of toxoplasma-associated disease
US-2025067735-A1 · Feb 27, 2025 · US
Toxoplasma
Toxoplasma · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/45 |
| Official title | Toxoplasma |
| Display label | Toxoplasma |
| Total patents | 26 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Engineered parasites for delivering protein to the central nervous system (cns)
US-2025057892-A1 · Feb 20, 2025 · US
Immunologically active fragments of toxoplasma gondii
US-12156906-B2 · Dec 3, 2024 · US
Engineered parasites for delivering protein to the central nervous system (CNS)
US-12070476-B2 · Aug 27, 2024 · US
Compositions and methods for regulation of chronic toxoplasma infection
US-11945845-B2 · Apr 2, 2024 · US
Pharmaceutical composition for preventing or treating inflammatory diseases including Toxoplasma gondii GRA9 protein or gene encoding the protein as active ingredient
US-11939360-B2 · Mar 26, 2024 · US
Virus-like particle comprising toxoplasma gondii protein and influenza virus protein, and diagnostic method using same
US-2024085420-A1 · Mar 14, 2024 · US
Virus-like particles containing CST1 protein and toxoplasma vaccine using same
US-2023149527-A1 · May 18, 2023 · US
Use of virus-like particles including toxoplasma gondii apical membrane antigen 1 for serodiagnosing toxoplasmosis
US-2023135784-A1 · May 4, 2023 · US
New serological marker for the latent form of toxoplasmosis
US-2022390449-A1 · Dec 8, 2022 · US
Pharmaceutical composition for preventing or treating inflammatory diseases including toxoplasma gondii gra9 protein or gene encoding the protein as active ingredient
US-2022306707-A1 · Sep 29, 2022 · US
Immunologically active fragments of toxoplasma gondii
US-2022288174-A1 · Sep 15, 2022 · US
Compositions and Methods for Regulation of Chronic Toxoplasma Infection
US-2022235101-A1 · Jul 28, 2022 · US
Engineered parasites for delivering protein to the central nervous system (cns)
US-2022160790-A1 · May 26, 2022 · US
Engineered parasites for delivering protein to the central nervous system (CNS)
US-11260081-B2 · Mar 1, 2022 · US
Novel toxoplasma gondii gra8-derived recombinant peptides and composition for preventing or treating cancer comprising the same
US-2021188916-A1 · Jun 24, 2021 · US
New attenuated strains of apicomplexa and their use as antigen vectors for the prevention of infectious diseases
US-2021139883-A1 · May 13, 2021 · US
Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin
US-10954520-B2 · Mar 23, 2021 · US
Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin
US-2020255483-A1 · Aug 13, 2020 · US
Engineered parasites for delivering protein to the central nervous system (cns)
US-2020121731-A1 · Apr 23, 2020 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/45?
- CPC C07K14/45 is the Cooperative Patent Classification code for “Toxoplasma.”
- How many patents are filed under CPC C07K14/45 (Toxoplasma)?
- Our database includes 26 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/45 growing?
- Publication counts under this code: 5 in 2024 vs 2 in 2025 (latest complete years).